These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3954382)

  • 1. [TNF induction in the serum and ascites of a gastric cancer patient treated with OK-432].
    Neda H; Watanabe N; Sone H; Yamauchi N; Niitsu Y; Urushizaki I
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 1):593-7. PubMed ID: 3954382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
    Mori H; Itoh N; Tamaya T
    Immunopharmacol Immunotoxicol; 1989; 11(1):33-53. PubMed ID: 2503555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of OK-432 induced endogenous TNF on tumor bearing mice and cancer patients.
    Watanabe N; Niitsu Y; Yamauchi N; Neda H; Sone H; Urushizaki I; Yamamoto A; Nagamuta M; Sugawara Y
    Immunopharmacol Immunotoxicol; 1988; 10(1):53-65. PubMed ID: 3361071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of advanced gastric cancer showing complete cure by immunochemotherapy with FT-207 and OK-432 confirmed by thorough histologic examination of total gastrectomy matter].
    Futatsuki K; Kanda Y; Shimada S; Ishibashi I; Takemori Y; Izuno O; Suda Y; Fujiwara M; Takubo K; Takayama S
    Gan No Rinsho; 1985 Jun; 31(7):870-6. PubMed ID: 3928945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
    Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of unresectable advanced gastric cancer with effective treatment by local administration of OK-432 on operation].
    Kodama M; Taniguchi T; Furukawa H; Takahashi T; Hara T
    Gan To Kagaku Ryoho; 1989 Jun; 16(6):2301-3. PubMed ID: 2735772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endoscopic intratumor administration of OK-432 in gastric cancer unsuitable for surgery.
    Nakazawa S; Yoshino J; Kijima Y; Yasumasa N; Ohhashi S; Mizutani K
    Endoscopy; 1989 Jul; 21(4):168-71. PubMed ID: 2776702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
    Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of cytokine levels in ascitic fluid after intraperitoneal administration of OK-432 or CDDP].
    Terashima M; Takagane A; Abe K; Kuboi M; Asahi H; Saito K
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2326-9. PubMed ID: 7944471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
    Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
    Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of tumor necrosis factor by administration of OK-432 in cancer patients.
    Kokunai I; Shimano T; Sekimoto K; Takeda T; Kobayashi T; Yayoi E; Yamamoto A; Mori T
    J Clin Lab Immunol; 1986 Dec; 21(4):169-71. PubMed ID: 3560194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of endoscopical administration of OK-432 in 4 patients with advanced esophageal or gastric cancer].
    Satomi T; Inoue S; Fujita T; Ogawa S; Honda H; Hayashi M
    Gan No Rinsho; 1989 Mar; 35(4):512-5. PubMed ID: 2541269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An autopsied case of an aged patient with advanced gastric cancer that showed a complete response to immunochemotherapy].
    Mizumoto S; Ohoue M; Takami Y; Iihara K; Kurokawa E; Akashi H; Aoki Y; Mori H; Okano K
    Gan No Rinsho; 1989 Dec; 35(15):1791-4. PubMed ID: 2514300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432.
    Hironaka K; Yamaguchi Y; Okita R; Okawaki M; Nagamine I
    Anticancer Res; 2006; 26(5B):3701-7. PubMed ID: 17094388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of cyclosporin-A (CsA) and interferon-gamma (INF-gamma) induces apoptosis in human gastric carcinoma cells.
    Morisaki T; Matsunaga H; Beppu K; Ihara E; Hirano K; Kanaide H; Mori M; Katano M
    Anticancer Res; 2000; 20(5B):3363-73. PubMed ID: 11131636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of malignant ascites by intraperitoneal injection of OK-432. Possible mechanism of the reduction of original tumor mass volume].
    Katano M; Mizoguchi T; Yamamoto H; Hisatsugu T; Torisu M
    Nihon Geka Gakkai Zasshi; 1987 Dec; 88(12):1676-83. PubMed ID: 3447033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in cytokine levels in ascitic fluid after intraperitoneal administration of OK-432].
    Terashima M; Takagane A; Abe K; Kuboi M; Asahi H; Saito K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1443-5. PubMed ID: 8373202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A double blind study of the evaluation of the optimal dose and its frequency in oral administration of OK-432 (Picibanil) by immunological parameters (the 1st report)].
    Shiraishi T; Nio Y; Imai S; Tsubono M; Morimoto H; Tseng CC; Tobe T; Tanaka T; Kitamura O; Sakanashi S
    Nihon Gan Chiryo Gakkai Shi; 1990 Apr; 25(4):799-811. PubMed ID: 2196311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Intratumor injection of OK-432-stimulated peripheral blood mononuclear cells: a significance of mononuclear cell-producing tumor inhibitory factor induced by OK-432].
    Mizoguchi T; Katano M; Yamamoto H; Hisatsugu T
    Nihon Geka Gakkai Zasshi; 1987 Jun; 88(6):794. PubMed ID: 3627102
    [No Abstract]   [Full Text] [Related]  

  • 20. Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.
    Yamaguchi Y; Satoh Y; Miyahara E; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
    Anticancer Res; 1995; 15(5B):2201-6. PubMed ID: 8572625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.